Two hypoxia sensor genes and their association with symptoms of acute mountain sickness in sherpas

Aviation Space and Environmental Medicine

Volumn 79, Issue 11, 2008, Pages 1056-1060

  Droma, Yunden ^a   Ota, Masao ^a   Hanaoka, Masayuki ^a   Katsuyama, Yoshihiko ^b   Basnyat, Buddha ^c,d   Neupane, Pritam ^d   Arjyal, Amit ^d   Pandit, Anil ^d   Sharma, Dependra ^d   Ito, Michiko ^a   Kubo, Keishi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c NEPAL INTERNATIONAL CLINIC   (Nepal)

^d Mountain Medicine Society of Nepal   (Nepal)

Author keywords

Acute mountain sickness (AMS); Genetic polymorphism; High altitude; Hypoxia inducible factor (HIF); Hypoxic sensor; Sherpas; Von Hippel Lindau tumor suppressor protein (VHL)

Indexed keywords

ALTITUDE DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HIF1A GENE; HUMAN; MALE; MOUNTAINEERING; NEPAL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SHERPA; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; VHL GENE;

ALTITUDE SICKNESS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NEPAL; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION GROUPS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 55249085826     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: 10.3357/ASEM.2361.2008     Document Type: Article

References (12)

1. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y, et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 2002; 32:614-21.
2. Bartsch P, Roach R. Acute mountain sickness and high-altitude cerebral edema. In: Hornbein TF, Schoene RB , eds. High altitude: an exploration of human adaptation., New York: Maecel Dekker; 2001:731-76.
3. Droma Y, Hanaoka M, Basnyat B, Arjyal A, Neupane P, Pandit A, et al. Symptoms of acute mountain sickness in Sherpas exposed to extremely high altitude. High Alt Med Biol 2006; 7:312-4.
4. thEd. New York: Oxford university press; 1995:146-161.
5. Hlatky MA, Quertermous T, Boothroyd DB, Priest JR, Glassford AJ, Myers RM, et al. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am Heart J 2007; 154:1035-42.
6. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIF-alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292:464-8.
7. Kayser B, Hoppeler H, Claassen H, Cerretelli P. Muscle structure and performance capacity of Himalayan Sherpas. J Appl Physiol 1991; 70:1938-42.
8. Keyl C, Schneider A, Greene RE, Passino C, Spadacini G, Bandinelli G, et al. Effects of breathing control on cardiocirculatory modulation in Caucasian lowlanders and Himalayan Sherpas. Eur J Appl Physiol 2000; 83:481-6.
9. Liu E, Percy MJ, Amos CI, Guan Y, Shete S, Stockton DW, et al. The worldwide distribution of the VHL 598C>T mutation indicates a single founding event. Blood 2004; 103:1937-40.
10. Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet 2004; 36:512-7.
11. Percy MJ, Mooney SM, McMullin MF, Flores A, Lappin TR, Lee FS. A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1alpha (HIF-1alpha) does not impair Pro-564 hydroxylation. Mol Cancer 2003; 2:31-7.
12. Smith TG, Brooks JT, Balanos GM, Lappin TR, Layton DM, Leedham DL, et al. Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiology. Adv Exp Med Biol 2008; 605:51-6.